Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-058701

Director sold 11,447 shares at $7.40 ($84,693)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Borgeson Blake · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-12 Sale : show line 1 in the form 10b5-1 −11,447 $7.40 $84,693 7,384,526 D
Open-market sales · 11,447 sh · avg $7.40 · $84,693
Loading xslF345X05/doc4.xml…